No Data
No Data
The market is weak, making it easier to sell on the rebound, but there is strong support at the lower level.
[Emerging Markets Individual Stock Strategy] Today, a weaker trend is expected in emerging markets. In the US stock market on the 27th yesterday, the Dow Jones average rose by $9.98 (+0.02%) to $41,250.50, slightly extending for the third consecutive day. The rise in long-term interest rates weighed on stock prices, while the unexpected improvement in the August consumer confidence index supported stock prices. In addition, with Nvidia's (NVDA) earnings report scheduled for the 28th, the high tech sector turned higher on expectations, supporting the market. The Dow reached an all-time high for consecutive days.
Buyers refrain from purchasing, being cautious about the soft market and aware of important events.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to have a soft development. In the U.S. stock market on the 22nd, the Dow Jones fell by 177.71 points (-0.43%) to 40,712.78 points, with second-hand home sales exceeding expectations leading to a rise in long-term interest rates, weighing on stock prices, particularly in the high-tech sector. In addition, profit-taking sales escalated with caution over the speech by Jerome Powell, Chairman of the Federal Reserve, causing the market to expand its decline towards the end. Today's emerging markets are dominated by selling.
Stocks that moved the day before part 2 include Cellseed, SHIFT, Astroscale, etc.
Stock name <code> 19th closing price & rarr; 7&iHD & lt; 3382 & gt; 2161 +400. Foreign securities were downgraded. Nitto Boseki <3110> 5840 +605 showed a golden cross of the day 25-day moving average. Investment funds flowed into Bio-related stocks due to earnings report passage, etc. Cellseed <7776> 671 +100. Tohoku Steel Industry <1835> 3245 +655 formed a golden cross by exceeding the 25-day line and the 75-day line. NetPro HD <7383> 286 +
Active and newly listed stocks during the morning session.
INPEX <1605> 2204 -37.5. The price of crude oil fell due to expectations of easing tensions in the Middle East. Pan Pacific HD <7532> 3519 -203. Predicted to have only 7% operating profit this year compared to a 33% increase in the previous period. Sumitomo Pharma <4506> 588 +34. Domestic securities raised the target stock price. Joukan Electric Industry <7711> 1560 +63. Revision of the national strategy for fusion power generation is the key. Asmark <4197> 2366 +400. Established a shareholder benefits system as part of the new global strategy.
Volume change rate ranking (9am) - RepliCel, Fujifilm Pharmaceuticals, etc. ranked in.
In the volume change rate ranking, by comparing the volume of the last 5 days with the volume on the delivery day, market participants can understand the trend of the market's interest. Top volume change rate [as of August 19, 9:32am] (compared to the average volume of the last 5 days): stock code, stock name, volume, 5-day average volume, volume change rate, and stock price change rate. <2389> Digital HD, 377200, 107185.08, 241.5%, 0% <488>
Reprocell is ranked in the Alzheimer's disease research paper, and its publication is being considered as important material again.
REPROCELL <4978> is ranked high (as of 9:32am). It is greatly extended. On the 15th, a paper was announced regarding the research on Alzheimer's disease using disease model cells derived from iPS cells developed by REPROCELL and three-dimensional culture substrates (Alvetex) from the group of CSO Stephan Schvoerski (Professor, Department of Biological Sciences, Durham University) of its subsidiary REPROCELL Europe. While it only rose slightly last weekend on the 16th, it is re-evaluated as a material.
No Data
No Data